Eckert & Ziegler logo

Eckert & Ziegler

Stock
Stock
ISIN: DE0005659700
Ticker: EUZ
DE0005659700
EUZ

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Eckert & Ziegler has so far distributed $0.251 in 2026. The next dividend will be paid on 29.06.2027


$0.124

CHART BY

Frequently asked questions

The market capitalization of Eckert & Ziegler is $889.44M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Eckert & Ziegler is 15.48. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Eckert & Ziegler's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.918. EPS indicates the company's profitability on a per-share basis.
Currently, 4 analysts cover Eckert & Ziegler's stock, with a consensus target price of $24.99. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Eckert & Ziegler reported a revenue of $361.12M.
Eckert & Ziegler's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $109.53M. EBITDA measures the company's overall financial performance.
Eckert & Ziegler has a free cash flow of $29.51M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Eckert & Ziegler employs approximately 1,116 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Eckert & Ziegler is 42.14M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$889.44M
EPS (TTM) 
$0.918
Free Float 
42.14M
P/E ratio (TTM) 
15.48
Revenue (TTM) 
$361.12M
EBITDA (TTM) 
$109.53M
Free Cashflow (TTM) 
$29.51M

Pricing

1D span
$14.16$14.44
52W span
$14.13$22.15

Analyst Ratings

The price target is $24.99 and the stock is covered by 4 analysts.

Buy

4

Hold

0

Sell

0

Information

Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.

Employees
1,116
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DE0005659700
Primary Ticker
EUZ

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation